These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 12170187)
1. Reducing renal accumulation of single-chain Fv against melanoma-associated proteoglycan by coadministration of L-lysine. Hamilton S; Odili J; Wilson GD; Kupsch JM Melanoma Res; 2002 Aug; 12(4):373-9. PubMed ID: 12170187 [TBL] [Abstract][Full Text] [Related]
2. Efficient in vivo targeting of malignant melanoma by single-chain Fv antibody fragments. Kang NV; Hamilton S; Sanders R; Wilson GD; Kupsch JM Melanoma Res; 1999 Dec; 9(6):545-56. PubMed ID: 10661765 [TBL] [Abstract][Full Text] [Related]
3. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen. Kang N; Hamilton S; Odili J; Wilson G; Kupsch J Clin Cancer Res; 2000 Dec; 6(12):4921-31. PubMed ID: 11156253 [TBL] [Abstract][Full Text] [Related]
4. Improved production by domain inversion of single-chain Fv antibody fragment against high molecular weight proteoglycan for the radioimmunotargeting of melanoma. Hamilton S; Odili J; Gundogdu O; Wilson GD; Kupsch JM Hybrid Hybridomics; 2001; 20(5-6):351-60. PubMed ID: 11839253 [TBL] [Abstract][Full Text] [Related]
5. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library. Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083 [TBL] [Abstract][Full Text] [Related]
6. The use of a cocktail of single chain Fv antibody fragments to improve the in vitro and in vivo targeting of melanoma. Pacifico MD; Pearl RA; Kupsch JM J Exp Clin Cancer Res; 2006 Mar; 25(1):45-53. PubMed ID: 16761617 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49. Chauhan SC; Jain M; Moore ED; Wittel UA; Li J; Gwilt PR; Colcher D; Batra SK Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):264-73. PubMed ID: 15791435 [TBL] [Abstract][Full Text] [Related]
8. Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose. Förster GJ; Santos EB; Smith-Jones PM; Zanzonico P; Larson SM J Nucl Med; 2006 Jan; 47(1):140-9. PubMed ID: 16391198 [TBL] [Abstract][Full Text] [Related]
9. Generation and selection of monoclonal antibodies, single-chain Fv and antibody fusion phage specific for human melanoma-associated antigens. Kupsch JM; Tidman N; Bishop JA; McKay I; Leigh I; Crowe JS Melanoma Res; 1995 Dec; 5(6):403-11. PubMed ID: 8589614 [TBL] [Abstract][Full Text] [Related]
10. Numerical selection of optimal tumor imaging agents with application to engineered antibodies. Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795 [TBL] [Abstract][Full Text] [Related]
11. The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs. Wittel UA; Jain M; Goel A; Chauhan SC; Colcher D; Batra SK Nucl Med Biol; 2005 Feb; 32(2):157-64. PubMed ID: 15721761 [TBL] [Abstract][Full Text] [Related]
12. Rapid imaging of human melanoma xenografts using an scFv fragment of the human monoclonal antibody H11 labelled with 111In. Reilly RM; Maiti PK; Kiarash R; Prashar AK; Fast DG; Entwistle J; Dan ; Narang SA; Foote S; Kaplan HA Nucl Med Commun; 2001 May; 22(5):587-95. PubMed ID: 11388583 [TBL] [Abstract][Full Text] [Related]
13. Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumors. Jain M; Chauhan SC; Singh AP; Venkatraman G; Colcher D; Batra SK Cancer Res; 2005 Sep; 65(17):7840-6. PubMed ID: 16140953 [TBL] [Abstract][Full Text] [Related]